Bellastesin (Bellasthesin)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Similar drugsTo uncover
Dosage form: & nbsppills
Composition:

For one tablet:

Active components:

Anestezine (benzocaine)

0.300 grams

Cleavers extract thick

0.015 g

Excipients:

Microcrystalline cellulose

0.035417 g

Oxypropylcellulose (giprolose)

0.008510 g

Croscarmellose sodium

0.003691 g

Talc

0.003691 g

Calcium stearate

0.003691 g

Weight of a tablet

0.370 g
Description:

Tablets are flat-cylindrical, with a facet and a risk, from light brown to brown with lighter and darker patches.

Pharmacotherapeutic group:Spasmolytic agent
ATX: & nbsp
  • Spasmolytics in combination with other drugs
    • Pharmacodynamics:

    Combined drug.

    Has spasmolytic, local anesthetic and analgesic effect; reduces the acidity of gastric juice, the tone of smooth muscle cells of the gastrointestinal tract.

    Indications:

    As a symptomatic agent for diseases of the gastrointestinal tract, accompanied by increased secretory function of the stomach and spasms of smooth muscles with the aim of arresting the pain syndrome (hyperacid gastritis, peptic ulcer and duodenal ulcer).

    Contraindications:

    Increased individual sensitivity to the components of the drug, zakratougolnaya glaucoma, prostatic hyperplasia, children's age.

    If you have any of these diseases, consult a doctor before taking the drug.
    Carefully:

    Patients with polyneuropathy, hyperthyroidism, ischemic heart disease, chronic heart failure, arterial hypertension, kidney disease, diaphragmatic hernia, reflux esophagitis.

    Pregnancy and lactation:

    Pregnant should be used only in the case when, according to the doctor, the benefit to the mother when applying the drug exceeds the potential risk to the fetus.

    In case of use by women breastfeeding, breastfeeding should be discontinued.

    Dosing and Administration:

    Inside, 1 tablet 2-3 times a day. The tablet is swallowed without chewing and washed down with water.

    The course of treatment is selected individually.

    If the symptoms do not go away within 3-5 days, you should consult your doctor to decide whether to continue using the drug.

    Side effects:

    Possible: dry mouth, loss of taste, appetite, mydriasis (dilated pupils), drowsiness, dizziness, tachycardia, speech disturbance, agitation (especially in elderly patients), paresis of accommodation, allergic reactions, difficulty urinating, constipation.

    If any of the side effects listed in the manual are aggravated, or if you notice any other side effects not listed in the instructions, inform the doctor about it.

    Overdose:To date, cases of overdose have not been reported.
    Interaction:

    The drug reduces the antibacterial activity of sulfonamides.

    Amantadine and quinidine increase the effect of the drug.

    With the simultaneous use of the drug with opioid analgesics and drugs that depress the central nervous system, it is possible to suppress the central nervous system; with haloperidol and organic nitrates - increased intraocular pressure; with glucocorticosteroids for systemic use - their effect is reduced and the intraocular pressure may increase; with M-holinoblokatorami - increased anticholinergic effect; with furosemide - orthostatic hypotension is possible.

    Reserpine, monoamine oxidase inhibitors, guanethidine, antacid agents, ascorbic acid, attapulgite reduce the effect of the drug.

    With the simultaneous use of the drug with antihistamines, the antihistamine effect increases; with beta-adrenoreceptor blockers, theirEffect; with hormonal contraceptives - the contraceptive effect decreases; with nonselective inhibitors of the reverse neuronal capture of monoamines - the sedative effect is enhanced.

    The drug reduces the effect of non-steroidal anti-inflammatory drugs, griseofulvin, digitoxin, doxycycline, ketoconazole, metoclopramide, metronidazole; increases the effect of indapamide, nizatidine.

    With simultaneous use with drugs containing potassium, the formation of ulcers in the intestine.

    Effect on the ability to drive transp. cf. and fur:

    Avoiding the use of the drug for people whose activities require increased visual acuity, high concentration of attention and rapid psychomotor reactions (vehicle management, working with moving mechanisms, dispatcher and operator work, etc.) should be avoided.

    Form release / dosage:Pills.
    Packaging:

    10 tablets per contour cell pack.

    50, 100 or 200 contour mesh packages, together with an equal number of instructions for use, are placed in a box or in a cardboard box.

    Storage conditions:

    In a dry, the dark place at a temperature of no higher than 25 ° C.

    Keep out of the reach of children.

    Shelf life:

    3 years.

    Do not use after the expiration date.

    Terms of leave from pharmacies:Without recipe
    Registration number:LP-002114
    Date of registration:28.06.2013
    Expiration Date:28.06.2018
    The owner of the registration certificate:VIFITEH, CJSC VIFITEH, CJSC Russia
    Manufacturer: & nbsp
    Representation: & nbspVIFITEH, CJSCVIFITEH, CJSC
    Information update date: & nbsp21.01.2017
    Illustrated instructions
      Instructions
      Up